Potent inhibition of Lewis lung cancer growth by heyneanol A from the roots of Vitis amurensis through apoptotic and anti-angiogenic activities

Carcinogenesis

Volumn 27, Issue 10, 2006, Pages 2059-2069

  Lee, Eun Ok ^a   Lee, Hyo Jung ^a   Hwang, Hwa Soo ^a   Ahn, Kyoo Seok ^a   Chae, Chanhee ^b   Kang, Kyung Sun ^b   Lu, Junxuan ^c   Kim, Sung Hoon ^a  

^a Kyung Hee University   (South Korea)

^b Seoul National University   (South Korea)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BASIC FIBROBLAST GROWTH FACTOR; BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; BENZYLOXYCARBONYLASPARTYLGLUTAMYLVALYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; CASPASE 9; CASPASE INHIBITOR; HEYNEANOL A; MATRIGEL; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PLANT EXTRACT; RESVERATROL; UNCLASSIFIED DRUG; VITIS AMURENSIS EXTRACT;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BODY WEIGHT DISORDER; CANCER CELL; CANCER INHIBITION; CAPILLARY; CELL ACTIVITY; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CHINESE MEDICINE; CONTROLLED STUDY; CULTURE MEDIUM; DISEASE MODEL; DOSE RESPONSE; DRUG MECHANISM; DRUG POTENCY; DRUG STABILITY; DRUG STRUCTURE; ENDOTHELIUM CELL; ENZYME DEGRADATION; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; INHIBITION KINETICS; INOCULATION; LEWIS CARCINOMA; LUNG CANCER; MOLECULAR MECHANICS; MOUSE; NICK END LABELING; NONHUMAN; PLANT ROOT; PRIORITY JOURNAL; RECEPTOR BINDING; TREATMENT OUTCOME; TUMOR VASCULARIZATION; UMBILICAL VEIN; VITACEAE;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CARCINOMA, LEWIS LUNG; CASPASE 3; CASPASE 9; CASPASES; CELL PROLIFERATION; FEMALE; FIBROBLAST GROWTH FACTOR 2; MICE; MICE, INBRED C57BL; PROLIFERATING CELL NUCLEAR ANTIGEN; STILBENES;

EID: 33749558110     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgl055     Document Type: Article

References (42)

1. Jiangsu New Medical College. (1997) Dictionary of Chinese Traditional Medicine. Shanghai Science and Technology Press, Shanghai, China, vol. 2, p. 2315.
2. Huang,K.S., Lin,M. and Cheng,G.F. (2001) Anti-inflammatory tetramers of resveratrol from the roots of Vitis amurensis and the conformations of the seven-membered ring in some oligostilbenes. Phytochemistry, 58, 357-362.
3. Li,W.W., Ding,L.S., Li,B.G. and Chen,Y.Z. (1996) Oligostibenes from Vitis heyneana. Phytochemistry, 42, 1163-1165.
4. Huang,K.S. and Lin,M. (1999) Oligostilebenes from the roots of Vitis amurensis. J. Asian Nat. Prod. Res., 2, 21-28.
5. Huang,K.S., Lin,M., Yu,L.N. and Kong,M. (2000) Four novel oligostilbenes from the roots of Vitis amurensis. Tetrahedron, 56, 1321-1329.
6. Bhat,K.P.L., Kosmeder,J.W. II and Pezzuto,J.M. (2001) Biological effects of resveratrol. Antioxid. Redox Signal., 3, 1041-1064.
7. Bianchini,F. and Vainio,H. (2003) Wine and resveratrol: Mechanisms of cancer prevention? Eur. J. Cancer Prev., 12, 417-425.
8. Pervaiz,S. (2003) Resveratrol: From grapevines to mammalian biology. FASEB J., 17, 1975-1985.
9. Boissy,P., Andersen,T.L., Abdallah,B.M., Kassem,M., Plesner,T. and Delaisse,J.M. (2005) Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoblast differentiation. Cancer Res, 65, 9943-9952.
10. Goldberg,D.M. (1996) More on antioxidant activity of resveratrol in red wine. Clin. Chem., 42, 113-114.
11. Delmas,D., Jannin,B. and Latruffe,N. (2005) Resveratrol: Preventing properties against vascular alterations and ageing. Mol. Nutr. Food Res, 49, 377-395.
12. Wang,Z., Zou,J., Huang,Y., Cao,K., Xu,Y. and Wu,JM. (2002) Effect of resveratrol on platelet aggregation in vivo and in vitro. Clin. Med. J. (Engl), 115, 378-380.
13. Park,J.W., Choi,Y.J., Suh,S.I. et al. (2001) Bcl-2 overexpression attenuates resveratrol-induced apoptosis in U937 cells by inhibition of caspase-3 activity. Carcinogenesis, 22, 1633-1639.
14. Ferry-Dumazet,H., Garnier,O., Mamani-Matsuda,M. et al. (2002) Resveratrol inhibits the growth and induces the apoptosis of both normal and leukemic hematopoietic cells. Carcinogenesis, 23, 1327-1333.
15. Joe,A.K., Liu,H., Suzui,M., Vural,M.E., Xiao,D. and Weinstein,I.B. (2002) Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin. Cancer Res., 8, 893-903.
16. Scarlatti,F., Sala,G., Somenzi,G., Signorelli,P., Sacchi,N. and Ghidoni,R. (2003) Resveratrol induces growth inhibition and apoptosis in metastatic breast cancer cells via de novo ceramide signaling. FASEB J., 17, 2339-2341.
17. Jang,M., Cai,L., Udeani,G.O. et al. (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science, 275, 218-220.
18. Clement,M.V., Hirpara,J.L., Chawdhury,S.H. and Pervaiz,S. (1998) Chemo-preventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood, 92, 996-1002.
19. Carbo,N., Costelli,P., Baccino,F.M., Lopez-Soriano,F.J. and Argiles,J.M. (1999) Resveratrol, a natural product present in wine, decreases tumor growth in a rat tumor model. Biochem. Biophys. Res. Comm., 27, 739-743.
20. Huang,C., Ma,W.Y., Goranson,A. and Dong,Z. (1999) Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. Carcinogenesis, 20, 237-242.
21. Holmes-McNary,M. and Baldwin,A.S. Jr (2000) Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IkappaB kinase. Cancer Res., 60, 3477-3483.
22. Ohyama,M., Tanaka,T., Ito,T., Iinuma,M., Bastow,K.F. and Lee,K.H. (1999) Antitumor agents 200. Cytotoxicity of naturally occurring resveratrol oligomers and their acetate derivatives. Bioorg. Med. Chem. Lett., 9, 3057-3060.
23. Ito,T., Akao,Y., Yi,H., Ohguchi,K., Matsumoto,K., Tanaka,T., Iinuma,M. and Nozawa,Y. (2003) Antitumor effect of resveratrol oligomers against human cancer cell lines and the molecular mechanism of apoptosis induced by vaticanol C. Carcinogenesis, 24, 1489-1497.
24. Lee,E.O., Kwon,B.M., Song,G.Y., Chae,C.H., Kim,H.M., Shim,I.S., Ahn,K.S. and Kim,S.H. (2004) Heyneanol A induces apoptosis via cytochrome c release and caspase activation in human leukemic U937 cells. Life Sci., 74, 2313-2326.
25. Huh,J.E., Lee,E.O., Kim,M.S., Kang,K.S., Kim,C.H., Cha,B.C., Surh,Y.J. and Kim,S.H. (2005) Penta-O-galloyl-beta-D-glucose suppresses tumor growth via inhibition of angiogenesis and stimulation of apoptosis: roles of cyclooxygenase-2 and mitogen-activated protein kinase pathways. Carcinogenesis, 26, 1436-1445.
26. Jaffe,E.A., Nachman,R.L., Becker,C.G. and Minick,C.R. (1973) Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest., 52, 2745-2756.
27. Jost,L.M., Kirkwood,J.M. and Whiteside,T.L. (1992) Improved short- and long-term XTT-based colorimetric cellular cytotoxicity assay for melanoma and other tumor cells. J. Immunol. Methods, 147, 153-165.
28. Giavazzi,R., Campbell,D.E., Jessup,J.M., Cleary,K. and Fidler,I.J. (1986) Metastatic behavior of tumor cells isolated from primary and metastatic human colorectal carcinomas implanted into different sites in nude mice. Cancer Res., 46, 1928-1933.
29. Alessandria,G., Filippeschi,S., Sinibaldi,P., Mornet,F., Passera,P., Spreafico,F., Cappa,P.M. and Gullino,P.M. (1987) Influence of gangliosides on primary and metastatic neoplastic growth in human and murine cells. Cancer Res., 47, 4243-4247.
30. Chirivi,R.G., Garofalo,A., Crimmin,M.J., Bawden,L.J., Stoppacciaro,A., Brown,P.D. and Giavazzi,R. (1994) Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor. Int. J. Cancer, 58, 460-464.
31. Herrmann,M., Lorenz,H.M., Vollm,R, Grunkem,M., Woithm,W. and Kaldenm,J.R. (1994) A rapid and simple method for the isolation of apoptotic DNA fragments. Nucleic Acids Res., 22, 5506-5507.
32. Grant,D.S., Kinsella,J.L., Fridman,R., Auerbach,R., Piasecki,B.A., Yamada,Y., Zain,M. and Kleinman,H.K. (1992) Interaction of endothelial cells with a laminin A chain peptide (SIKVAV) in vitro and induction of angiogenic behavior in vivo. J. Cell Physiol., 153, 614-625.
33. Drabkin,D.S. and Ausinm,J.H. (1932) Spectrophotometric constants for common hemoglobin derivatives in human, dog, and rabbit blood. J. Biol. Chem., 98, 719.
34. Larrosa,M., Tomas-Barberan,F.A. and Espin,J.C. (2003) Grape polyphenol resveratrol and the related molecule 4-hydroxystilbene induce growth inhibition, apoptosis, S-phase arrest and upregulation of cyclins A,E and B1 in human SK-Mel-28 melanoma cells. J. Agric. Food Chem., 51, 4576-4584.
35. Bergers,G. and Benjamin,L. (2002) Tumorigenesis and the angiogenic switch. Nat. Rev. Cancer, 3, 401-410.
36. Folkman,J. (2003) Angiogenesis and apoptosis. Semin. Cancer Biol., 13, 159-167.
37. Kolenko,V.M., Uzzo,R.G., Bukowski,R. and Finke,J.H. (2000) Caspase-dependent and independent death pathways in cancer therapy. Apoptosis, 5, 17-20.
38. Shi,Y. (2002) Mechanisms of caspase activation and inhibition during apoptosis. Mol. Cell, 9, 459-470.
39. Griffioen,A.W. and Molema,G. (2000) Angiogenesis: Potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol. Rev., 52, 237-268.
40. Hasan,J., Shnyder,S.D., Clamp,A.R. et al. (2005) Heparin octasaccharides inhibit angiogenesis in vivo. Clin. Cancer Res., 11, 8172-8179.
41. Surh,Y.J. (2003) Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer, 3, 768-780.
42. Igney,F.H. and Krammer,P.H. (2002) Death and anti-death: Tumor resistance to apoptosis. Nat. Rev. Cancer, 2, 277-288.